View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Kidney Care Community News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 30, 2020
1 min read
Save

Results show benefits of drug to treat primary hyperoxaluria type 1 in young children

Results show benefits of drug to treat primary hyperoxaluria type 1 in young children

Phase 3 results from the Illuminate-B study suggest lumasiran, an investigational RNA interference therapeutic, may be safe and effective for treating pediatric patients who have primary hyperoxaluria type 1.

SPONSORED CONTENT
September 30, 2020
2 min read
Save

Midlife obesity shows varying impacts on kidney disease risk based on sex, race

Midlife obesity shows varying impacts on kidney disease risk based on sex, race

Researchers from Johns Hopkins found both Black and white women who were obese at midlife had increased risks for eGFR decline and end-stage kidney disease after 30 years of follow-up.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
September 28, 2020
1 min read
Save

Younger kidney donors lead to better chance of graft survival

The association of donor-recipient size mismatch on long-term graft survival is influenced greatly by recipient and donor age, according to findings from a recently published study.

SPONSORED CONTENT
September 24, 2020
1 min read
Save

Education program increases staff knowledge of peritoneal dialysis

Education program increases staff knowledge of peritoneal dialysis

After a peritoneal dialysis education program, the number of staff at a Veterans Affairs center who scored their knowledge level on the topic as “high” and “very high” increased, according to presented research.

SPONSORED CONTENT
September 23, 2020
3 min read
Save

Canagliflozin most effective in higher-risk patients for cardiovascular, kidney outcomes

Canagliflozin most effective in higher-risk patients for cardiovascular, kidney outcomes

Using the Kidney Disease: Improving Global Outcomes criteria, researchers found patients with type 2 diabetes who were at higher risk for adverse cardiovascular and kidney outcomes reaped the most benefits from canagliflozin.

SPONSORED CONTENT
September 22, 2020
1 min read
Save

Randomized clinical trial participation does not impact dialysis facility quality scores

Randomized clinical trial participation does not impact dialysis facility quality scores

Patients meet clinical quality targets equally at dialysis facilities that participate vs. centers that do not participate in randomized clinical trials, according to presented research.

SPONSORED CONTENT
September 21, 2020
1 min read
Save

Outset Medical raises $277 million in Wall Street debut

Outset Medical raises $277 million in Wall Street debut

With the closing of its initial public offering of 10,293,777 shares of common stock last week, dialysis machine manufacturer Outset Medical Inc. has raised $277.9 million, the company announced.

SPONSORED CONTENT
September 18, 2020
2 min read
Save

CMS finalizes ESRD Treatment Choices model, estimates $23 million in savings

CMS finalizes ESRD Treatment Choices model, estimates $23 million in savings

CMS released the final version of its ESRD Treatment Choices payment model today, aimed at incentivizing dialysis providers to place more patients with end-stage renal disease on home dialysis or refer them for a kidney transplant.

SPONSORED CONTENT
September 18, 2020
1 min read
Save

FDA approves new drug application for phosphorus drug

FDA approves new drug application for phosphorus drug

Ardelyx Inc. recently announced the FDA has accepted its new drug application of tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.

SPONSORED CONTENT
September 16, 2020
4 min read
Save

Belimumab plus standard therapy superior to standard therapy alone for lupus nephritis

Belimumab plus standard therapy superior to standard therapy alone for lupus nephritis

A 2-year randomized controlled trial has found that belimumab plus standard therapy is superior to standard therapy alone in patients with lupus nephritis, according to data published in the New England Journal of Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails